The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
Open accessAbstract
Virtually all cases of cervical cancer are caused by persistent infections with a restricted set of human papillomaviruses (HPV). Some HPV types, like HPV16 and HPV18, are clear and powerful carcinogens. However, the categorization of the most weakly carcinogenic HPV types is extremely challenging. The decisions are important for screening test and vaccine development. This article describes for open discussion an approach recently taken by a World Health Organization International Agency for Research on Cancer (IARC) Monographs Working Group to re-assess the carcinogenicity of different HPV types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Self-citationA review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22527 · Cited by 1,686
Self-citationde Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669 · cited 3×
“By this logic, four more types were categorized as having sufficient epidemiologic evidence leading to their classifiTable 2: Meta-analyses of type-specific HPV DNA prevalence in invasive cervical cancer [15] and women with normal cytology [14,17]”
Self-citationHPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,321
Khan, M. J., Castle, P. E., Lorincz, A. T., Wacholder, S., Sherman, M., Scott, D. R., Rush, B. B., Glass, A. G., & Schiffman, M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji187 · Cited by 1,053
Self-citationBosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Self-citationCarcinogenicity of human papillomaviruses
Cogliano, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., & Ghissassi, F. E. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70086-3 · Cited by 688
Clifford, G. M., Smith, J. S., Aguado, T., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601024 · Cited by 684
Self-citationClifford, G. M., Rana, R. K., Franceschi, S., Smith, J. S., Gough, G., & Pimenta, J. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0812 · Cited by 533
Self-citationThe carcinogenicity of human papillomavirus types reflects viral evolution
Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Cecilia Rodriguez, A., Bratti, M. C., Sherman, M. E., Morales, J., Guillen, D., et al. (2005) · Virology · doi:10.1016/j.virol.2005.04.002 · Cited by 441
Self-citationMolecular diagnosis of human papillomavirus (HPV) infections
Molijn, A., Kleter, B., Quint, W., & Doorn, L.-J. V. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.004 · Cited by 317
Human Papillomavirus Genotypes and the Cumulative 2‐Year Risk of Cervical Precancer
Wheeler, C. M., Hunt, W. C., SCHIFFMAN, M. H., Castle, P. E., & Atypical Squamous Cells of Undetermined Significance/Low‐Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group (2006) · The Journal of Infectious Diseases · doi:10.1086/507909 · Cited by 145
Self-citationA Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests
SCHIFFMAN, M. H., Khan, M. J., Solomon, D., Herrero, R., Wacholder, S., Hildesheim, A., Rodríguez, A. C., Bratti, M. C., Wheeler, C. M., Burk, R. D., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji014 · Cited by 144
Self-citationNew Technologies in Cervical Cancer Screening
Gravitt, P. E., Coutlée, F., Iftner, T., Sellors, J. W., Quint, W. G. V., & Wheeler, C. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.002 · Cited by 122
Clifford, G. M., & Franceschi, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.23282 · Cited by 91
Self-citationWentzensen, N., SCHIFFMAN, M. H., Dunn, S. T., Zuna, R. E., Walker, J. L., Allen, R. A., Zhang, R., Sherman, M. E., Wacholder, S., Jerónimo, J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23969 · Cited by 88
Self-citationGargiulo, F., De Francesco, M. A., Schreiber, C., Ciravolo, G., Salinaro, F., Valloncini, B., & Manca, N. (2007) · Virus Research · doi:10.1016/j.virusres.2006.12.017 · Cited by 81
From India to the World — A Better Way to Prevent Cervical Cancer
SCHIFFMAN, M. H., & Wacholder, S. (2009) · New England Journal of Medicine · doi:10.1056/nejme0901167 · Cited by 56
Self-citationThe evolving definition of carcinogenic human papillomavirus
Castle, P. E. (2009) · Infectious Agents and Cancer · doi:10.1186/1750-9378-4-7 · Cited by 44
Cited by
de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,066
Self-citationCarcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citationHuman Papillomavirus Testing in the Prevention of Cervical Cancer
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759
Self-citation
Metadata
- Authors
- Schiffman, M., Clifford, G., & Buonaguro, F. M.
- Venue
- Infectious Agents and Cancer
- Published
- 2009-06-01
- Volume
- 4
- Issue
- 1
- Pages
- 8-8
- ISSN
- 1750-9378 (ISSN-L)
- OpenAlex
- W2091307968
- Cited by
- 448
- References
- 20
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.